复发有没有影响? 来自精神分裂症新数据的洞察力
Oliver Howes1, Maria Kapi1, Bernard R Bukala1
1Institute of Psychiatry, Psychology and Neuroscience, https://ror.org/0220mzb33King's College London, UK.
The British journal of psychiatry : the journal of mental science
|November 10, 2025
概括
精神健康状况的复发可能并不总是导致症状或生活质量的长期不良结果. 个人因素对抗精神病药物维持治疗的决定有很大影响,以防止复发.
科学领域:
- 精神病学和心理健康 精神病学和心理健康
- 临床心理学 临床心理学
背景情况:
- 传统观点将复发与持久的负面长期结果联系在一起.
- 新出现的数据表明,复发和患者福祉之间的关系更为细微.
研究的目的:
- 重新评估复发对各种患者结局的长期影响.
- 探索个人情况如何影响抗精神病维持治疗的治疗决策.
主要方法:
- 审查关于复发的最新数据及其与症状,社会功能,生活质量和就业的相关性.
- 分析复发,相关风险,成本和个体患者因素之间的相互作用.
主要成果:
- 新的数据挑战了在复发后普遍存在的长期不良结果的假设.
- 突出了个人情况对治疗决策的影响.
结论:
- 复发可能并不总是预测所有领域的长期结果差.
- 考虑到个体患者情况的个性化治疗策略对于抗精神病维持治疗决策至关重要.
相关概念视频
Psychological and Sociocultural Causes of Schizophrenia
459
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
459
Biological Causes of Schizophrenia
472
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
472
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
Psychosis and Antipsychotic Drugs: Overview
788
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
788
Drug Therapy
236
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
236
Psychosis: Goals of Pharmacotherapy
453
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
453


